MIME-Version: 1.0
Content-Location: file:///C:/E9675736/RU-486.htm
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset="us-ascii"

<html xmlns:v=3D"urn:schemas-microsoft-com:vml"
xmlns:o=3D"urn:schemas-microsoft-com:office:office"
xmlns:w=3D"urn:schemas-microsoft-com:office:word"
xmlns:st1=3D"urn:schemas-microsoft-com:office:smarttags"
xmlns=3D"http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=3DContent-Type content=3D"text/html; charset=3Dus-ascii">
<meta name=3DProgId content=3DWord.Document>
<meta name=3DGenerator content=3D"Microsoft Word 11">
<meta name=3DOriginator content=3D"Microsoft Word 11">
<link rel=3DFile-List href=3D"RU-486_files/filelist.xml">
<title>RU-486</title>
<o:SmartTagType namespaceuri=3D"urn:schemas-microsoft-com:office:smarttags"
 name=3D"address"/>
<o:SmartTagType namespaceuri=3D"urn:schemas-microsoft-com:office:smarttags"
 name=3D"PostalCode"/>
<o:SmartTagType namespaceuri=3D"urn:schemas-microsoft-com:office:smarttags"
 name=3D"State"/>
<o:SmartTagType namespaceuri=3D"urn:schemas-microsoft-com:office:smarttags"
 name=3D"Street"/>
<o:SmartTagType namespaceuri=3D"urn:schemas-microsoft-com:office:smarttags"
 name=3D"City"/>
<o:SmartTagType namespaceuri=3D"urn:schemas-microsoft-com:office:smarttags"
 name=3D"place"/>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>Ali Carroll</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>Ali Carroll</o:LastAuthor>
  <o:Revision>2</o:Revision>
  <o:TotalTime>44</o:TotalTime>
  <o:Created>2006-06-19T20:08:00Z</o:Created>
  <o:LastSaved>2006-06-19T20:08:00Z</o:LastSaved>
  <o:Pages>1</o:Pages>
  <o:Words>546</o:Words>
  <o:Characters>3117</o:Characters>
  <o:Company>Circle Cross Farm</o:Company>
  <o:Lines>25</o:Lines>
  <o:Paragraphs>7</o:Paragraphs>
  <o:CharactersWithSpaces>3656</o:CharactersWithSpaces>
  <o:Version>11.5606</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:Zoom>BestFit</w:Zoom>
  <w:SpellingState>Clean</w:SpellingState>
  <w:GrammarState>Clean</w:GrammarState>
  <w:DrawingGridHorizontalSpacing>6 pt</w:DrawingGridHorizontalSpacing>
  <w:DisplayHorizontalDrawingGridEvery>2</w:DisplayHorizontalDrawingGridEve=
ry>
  <w:DisplayVerticalDrawingGridEvery>2</w:DisplayVerticalDrawingGridEvery>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:Compatibility>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:UseWord2002TableStyleRules/>
  </w:Compatibility>
  <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>
 </w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState=3D"false" LatentStyleCount=3D"156">
 </w:LatentStyles>
</xml><![endif]--><!--[if !mso]><object
 classid=3D"clsid:38481807-CA0E-42D2-BF39-B33AF135CC4D" id=3Dieooui></objec=
t>
<style>
st1\:*{behavior:url(#ieooui) }
</style>
<![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:"Arial Black";
	panose-1:2 11 10 4 2 1 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Arial;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
h2
	{mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	mso-outline-level:2;
	font-size:18.0pt;
	font-family:"Times New Roman";
	color:#245890;}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{color:purple;
	text-decoration:underline;
	text-underline:single;}
span.SpellE
	{mso-style-name:"";
	mso-spl-e:yes;}
span.GramE
	{mso-style-name:"";
	mso-gram-e:yes;}
@page Section1
	{size:8.5in 11.0in;
	margin:1.0in 1.0in 1.0in 1.0in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman";
	mso-ansi-language:#0400;
	mso-fareast-language:#0400;
	mso-bidi-language:#0400;}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext=3D"edit" spidmax=3D"3074"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext=3D"edit">
  <o:idmap v:ext=3D"edit" data=3D"1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=3DEN-US link=3Dblue vlink=3Dpurple style=3D'tab-interval:.5in'>

<div class=3DSection1>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
style=3D'font-size:14.0pt;font-family:"Arial Black"'>RU-486<o:p></o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'text-align:justify'>RU-486 is a drug that pro=
duces an
abortion. It is a pill taken after the mother misses her period. It can be =
used
up to the second month of pregnancy. It works by blocking progesterone, a c=
rucial
hormone during pregnancy. Without progesterone, the uterine lining does not
provide food, fluid and oxygen to the tiny developing baby. The baby cannot
survive. A second drug is given which stimulates the uterus to contract and
expel the dead baby.</p>

<p class=3DMsoNormal style=3D'text-align:justify'>It sounds so easy&#8230; =
take a
pill and you abort. <i style=3D'mso-bidi-font-style:normal'>Easy, safe and =
cheap</i>
and it benefits women. This is how RU-486, known as the abortion pill, is b=
eing
described. Yet, this is an issue of <u>life and death</u>. You must look be=
yond
the words to find the truth.</p>

<p class=3DMsoNormal style=3D'text-align:justify'><o:p>&nbsp;</o:p></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b style=3D=
'mso-bidi-font-weight:
normal'><i style=3D'mso-bidi-font-style:normal'><u><span style=3D'color:nav=
y'>&#8220;Easy&#8221;<o:p></o:p></span></u></i></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span style=3D'color:navy=
'>When a
woman takes RU-486 she experiences severe cramping, nausea, vomiting and
bleeding. Lester Hyman, a spokesman for the manufacturer of RU-486, <span
class=3DSpellE>Roussel-Uclaf</span>, admitted &#8220;<i style=3D'mso-bidi-f=
ont-style:
normal'>there is considerable pain with the procedure</i>&#8221;. The emoti=
onal
distress, however, may have even more impact. Rather than being &#8220;over
with&#8221; in a few minutes (as in a surgical abortion) this abortion could
last for over a week. When the woman finally does abort, she will expel a t=
iny
dead human being &#8211; her baby. There will be no denying what is really
aborted! <span class=3DSpellE>Edouard</span> <span class=3DSpellE>Sakiz</sp=
an>, the
former president of <span class=3DSpellE>Roussel-Uclaf</span> admits that R=
U-486
abortions involve &#8220;<i style=3D'mso-bidi-font-style:normal'>an appalli=
ng
psychological ordeal</i>&#8221;. <o:p></o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span class=
=3DGramE><b
style=3D'mso-bidi-font-weight:normal'><i style=3D'mso-bidi-font-style:norma=
l'><span
style=3D'color:navy'>So much for</span></i></b><span style=3D'color:navy'> =
<b
style=3D'mso-bidi-font-weight:normal'><i style=3D'mso-bidi-font-style:norma=
l'>&#8220;easy&#8221;.</i></b></span></span><span
style=3D'color:navy'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span style=3D'color:#245=
890'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b style=3D=
'mso-bidi-font-weight:
normal'><i style=3D'mso-bidi-font-style:normal'><u><span style=3D'color:mar=
oon'>&#8220;Safe&#8221;<o:p></o:p></span></u></i></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span style=3D'color:maro=
on'>In
July 1996, an FDA advisory panel heard the testimony of Dr. Mark <span
class=3DSpellE>Louviere</span>, telling of his experience treating a woman =
who
had taken RU-486 for an abortion. She had lost 1/2 to 2/3 of her blood. She=
 is
just one of an estimated 15,000 to 30,000 women a year who will suffer
complications from this drug. This is based on the <span class=3DSpellE>ant=
icpated</span>
<span class=3DGramE>rate<span style=3D'mso-spacerun:yes'>&nbsp; </span>of</=
span>
complications by The Population Council, who hold the patent for RU-486. Th=
e <span
class=3DSpellE>anticpate</span> a 1% to 2% complication rate, including car=
diac
arrest, hemorrhage, and incomplete abortions. <span class=3DGramE>If this f=
igure
is projected on the 1.5 million abortions done in this country each year, t=
hat
percentage represents an alarming number of women suffering complications e=
very
year.</span><o:p></o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><i style=3D=
'mso-bidi-font-style:
normal'><span style=3D'color:maroon'>&#8220;Safe&#8221; is dangerous for wo=
men.<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span style=3D'color:maro=
on'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b style=3D=
'mso-bidi-font-weight:
normal'><i style=3D'mso-bidi-font-style:normal'><u><span style=3D'color:#00=
3300'>&#8220;Cheap&#8221;<o:p></o:p></span></u></i></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span style=3D'color:#003=
300'>In <st1:place
w:st=3D"on">Europe</st1:place>, where RU-486 abortions are common, the cost=
s are
the same as surgical abortions because they require more staff, careful
monitoring and three or more visits to the clinic or hospital. Add to this =
the
complication that one in 10 women fail to abort and must undergo a surgical
abortion anyway. <o:p></o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b style=3D=
'mso-bidi-font-weight:
normal'><i style=3D'mso-bidi-font-style:normal'><span style=3D'color:#00330=
0'>&#8220;Cheap&#8221;
just became very expensive!<o:p></o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span style=3D'color:#003=
300'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b style=3D=
'mso-bidi-font-weight:
normal'><i style=3D'mso-bidi-font-style:normal'><u><span style=3D'color:pur=
ple'>&#8220;Benefits
women&#8221;<o:p></o:p></span></u></i></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span style=3D'color:purp=
le'>RU-486
is not about benefiting women. It&#8217;s about population control. The
manufacturer, Roussel-Uclaf, was very hesitant to apply for FDA approval. T=
hey
knew this drug created health complications that could lead to expensive
lawsuits. Then the <st1:City w:st=3D"on"><st1:place w:st=3D"on">Clinton</st=
1:place></st1:City>
administration, because of their commitment to control of world population,
stepped in to help get RU-486 approved. Unable to convince Roussel-Uclaf to
begin FDA approval proceedings, a deal was negotiated where Roussel-Uclaf w=
ould
donate the patent for RU-486 to The Population Council. It was further
negotiated that RU-486 would be able to attain FDA approval with only $8
million in drug testing trials instead of the normal $100 million or more.
RU-486 was &#8220;fast tracked&#8221; through the testing process. Most dru=
gs
go through rigorous and lengthy testing by the FDA before gaining approval =
to
be prescribed to the general public. Instead of six years or more, which is
typical for most drugs, the length of testing for RU-486 was reduced to six
months. <o:p></o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b style=3D=
'mso-bidi-font-weight:
normal'><i style=3D'mso-bidi-font-style:normal'><span style=3D'color:purple=
'>Does
this sound like it &#8220;benefits women&#8221;?<o:p></o:p></span></i></b><=
/p>

<p class=3DMsoNormal style=3D'text-align:justify'><span style=3D'color:#003=
300'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span style=3D'color:#003=
300'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><i style=3D'mso-bidi-font=
-style:
normal'><span style=3D'font-size:10.0pt;color:#003300'><o:p>&nbsp;</o:p></s=
pan></i></p>

<p class=3DMsoNormal style=3D'text-align:justify'><i style=3D'mso-bidi-font=
-style:
normal'><span style=3D'font-size:10.0pt;color:#003300'>This information is =
from a
publication by Heritage House &#8217;76, Inc., <span class=3DGramE>919</spa=
n> So.
<st1:address w:st=3D"on"><st1:Street w:st=3D"on">Main St.</st1:Street>, <st=
1:City
 w:st=3D"on">Snowflake</st1:City>, <st1:State w:st=3D"on">AZ</st1:State> <s=
t1:PostalCode
 w:st=3D"on">85937</st1:PostalCode></st1:address><o:p></o:p></span></i></p>

</div>

</body>

</html>

